openPR Logo
Press release

Exocrine Pancreatic Insufficiency (EPI) Therapeutics- Pipeline Analysis

Exocrine Pancreatic Insufficiency (EPI) Therapeutics-

Exocrine pancreatic insufficiency (EPI) is the inability of pancreas to produce enough enzymes for the proper breakdown and absorption of nutrients. The common causes of EPI are damage to pancreas, inflammation of pancreas, pancreatic surgery, and inherited disorders like Crohn’s disease and celiac disease.

Download the sample report at: https://www.pharmaproff.com/request-sample/1024

Some symptoms observed during EPI are pain or tenderness in belly, bad-smelling bowel movements, gas, diarrhea and feeling of fullness. EPI can be treated by pancreatic enzyme replacement therapy (PERT) and medications.

Get the detailed analysis at: https://www.pharmaproff.com/report/epi-therapeutics-pipeline-analysis

This disease can be prevented by eating six small meals a day, avoiding alcohol, taking vitamins and following a healthy diet. Cilian AG is in the process of developing Cilase as an orally active substance for the treatment of EPI in humans. Other than this AzurRx BioPharma Inc. is also in the process of developing MS1819 for the treating EPI.

Make enquiry before purchase at: https://www.pharmaproff.com/enquiry/1024

• The report provides a comprehensive understanding of the pipeline activities covering all drug candidates under various stages of development, with the detailed analysis of pipeline and clinical trials.
• Pipeline analysis of drugs by phases includes product description and development activities including information about clinical results, designations, collaborations, licensing, grants, technology, and others.

About Us:
Pharma Proff, is a frontline market intelligence and consulting solutions provider catering to the information and data needs of burgeoning sectors across the world, including pharmaceutical and healthcare. With meticulously curated research reports on the industry landscape, we empower companies in the healthcare and pharmaceutical sectors to make informed business decisions and base their marketing strategies with astuteness.

Contact:
Pharma Proff
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@pharmaproff.com
Web: https://www.pharmaproff.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Exocrine Pancreatic Insufficiency (EPI) Therapeutics- Pipeline Analysis here

News-ID: 1750389 • Views: 160

More Releases for EPI

Exocrine Pancreatic Insufficiency (EPI) Therapeutics Market Opportunity Analysis …
Exocrine pancreatic insufficiency (EPI) is a condition associated with deficiency of exocrine pancreatic enzymes that results in the inability to digest food or maldigestion. EPI may be associated with certain diseases and conditions that affect the pancreas such as cystic fibrosis, chronic pancreatitis, Shwachman–Diamond syndrome, and others. Chronic pancreatitis (CP) is the most common cause of EPI in adults that is followed by cystic fibrosis (CF). CF is an inherited
Global Epi Wafer Market 2018 - Nichia, EpiWorks, Norstel, OMMIC
Eminent Market, recently published a detailed market research study focused on the "Epi Wafer Market" across the global, regional and country level. The report provides 360° analysis of "Epi Wafer Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Epi Wafer industry, and estimates the future trend of Epi Wafer market on
United States Epi Wafer Market: Moving Towards a Brighter Future
Qyresearchreports include new market research report Epi Wafer to its huge collection of research reports. The report here assembles exchange points of view having a place with the United states Epi Wafer market which verbalizes the present-day information and future exposures with reference to the dynamic forces at play. The prime explanation for the examination report is to offer the endorser with a wide outline and make open the satisfying substances
Epi Wafer Market 2017 - GlobalWafers, Nichia, EpiWorks
Apex Research, recently published a detailed market research study focused on the "Epi Wafer Market" across the global, regional and country level. The report provides 360° analysis of "Epi Wafer Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Epi Wafer industry, and estimates the future trend of Epi Wafer market on
Epitaxial (Epi) Wafer Market 2017- ASM International, EpiWorks, Jenoptik
Marketreports.biz, recently published a detailed market research study focused on the "Epitaxial (Epi) Wafer Market" across the global, regional and country level. The report provides 360° analysis of "Epitaxial (Epi) Wafer Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Epitaxial (Epi) Wafer industry, and estimates the future trend of Epitaxial
Global Epi Wafer Market 2017 : EpiWorks, GlobalWafers, Nichia, Jenoptik, Norstel
A market study based on the " Epi Wafer Market " across the globe, recently added to the repository of Market Research, is titled ‘Global Epi Wafer Market 2017’. The research report analyses the historical as well as present performance of the worldwide Epi Wafer industry, and makes predictions on the future status of Epi Wafer market on the basis of this analysis. Sample Copy of Report : http://bit.ly/2r1uV4A Top Manufacturers Companies